Ledger.Open graph →
SEC Form D · filed September 14, 2020

NORTHWEST BIOTHERAPEUTICS INC

Offering
$2.6M
Sold
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BETHESDA, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jerry J. Jasinowski · Bethesda, MDDirectorLeslie J. Goldman · Bethesda, MDExecAlton L. Boynton · Bethesda, MDExec · DirectorLinda F. Powers · Bethesda, MDExec · DirectorNavid J. Malik · Bethesda, MDDirectorJ C. Black · Bethesda, MDDirectorMarnix L. Bosch · Bethesda, MDExecNavid J. Malik · Bethesda, MDDirectorJerry J. Jasinowski · Bethesda, MDDirectorLeslie J. Goldman · Bethesda, MDExecJ C. Black · Bethesda, MDDirectorAlton L. Boynton · Bethesda, MDExec · DirectorMarnix L. Bosch · Bethesda, MDExecLinda F. Powers · Bethesda, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗